Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-023716
Filing Date
2023-08-14
Accepted
2023-08-14 16:34:08
Documents
62
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q zvra20230630_10q.htm   iXBRL 10-Q 1129678
2 EXHIBIT 10.1 ex_528364.htm EX-10.1 15943
3 EXHIBIT 31.1 ex_523998.htm EX-31.1 13777
4 EXHIBIT 31.2 ex_523999.htm EX-31.2 13879
5 EXHIBIT 32.1 ex_524000.htm EX-32.1 7011
6 EXHIBIT 32.2 ex_524001.htm EX-32.2 7290
  Complete submission text file 0001437749-23-023716.txt   5634630

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA kmph-20230630.xsd EX-101.SCH 52429
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20230630_cal.xml EX-101.CAL 49800
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20230630_def.xml EX-101.DEF 352297
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20230630_lab.xml EX-101.LAB 326239
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20230630_pre.xml EX-101.PRE 373227
56 EXTRACTED XBRL INSTANCE DOCUMENT zvra20230630_10q_htm.xml XML 832067
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 231171156
SIC: 2834 Pharmaceutical Preparations